Business
Currency:USD
2024/Q1
Stock NameRevenueRatio
Diagnostic tests13.8M93.10%
Biopharmaceutical Services and other1.02M6.90%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States49.09M100.00%